Evaluation of mean corpuscular volume difference as a marker for serum hypertonicity during water deprivation in dogs

The mean cell volume difference (dMCV) reflects serum hypertonicity in diabetic dogs

Serum hypertonicity may develop during diabetes mellitus due to hyperglycemia and other biochemical changes. Hypertonicity may produce detrimental cellular and systemic effects and has been identified as a serum marker for some clinical disorders. In non-diabetic dogs, the mean cell volume difference, a novel erythrocyte measure, is increased by serum hypertonicity. However, it is not known whether hyperglycemic hypertonicity produces a similar change. The hypothesis that the mean cell volume difference could detect serum hypertonicity in diabetes was investigated in a group of thirty-two dogs with naturally-occurring diabetes mellitus that were prospectively recruited over a 1-year period from the outpatient population of a veterinary teaching hospital. The effect of hyperglycemia on the mean cell volume difference and the ability of the mean cell volume difference to predict serum hypertonicity were examined. Serum hyperosmolality and hypertonicity due to hyperglycemia was present in 91% and 94% of dogs, respectively. Hyperglycemia was the principal cause identified for serum hypertonicity and hyperosmolality. Using a cut-off value of ≥ 3 μm3 for the mean cell volume difference, serum hypertonicity ≥ 320 mmol/kg was identified with 79% sensitivity and 61% specificity. The dMCV correlated with changes in serum glucose, tonicity, and measured osmolality. Dogs with a mean cell volume difference ≥ 3 μm3 were at risk for serum tonicity ≥ 320 mmol/kg (risk ratio = 2.2) and serum glucose ≥ 13.9 mmol/L (risk ratio = 2.3). In conclusion, the mean cell volume difference is a useful surrogate marker for detecting serum hypertonicity in diabetic dogs and elevated mean cell volume difference is associated with increased risks for clinically relevant serum hypertonicity and hyperglycemia.

Stability of osmolality in previously frozen canine serum and urine samples

BACKGROUND

The measurement of osmolality is of interest in several clinical conditions and has been investigated in multiple veterinary studies. However, the stability of osmolality over time in frozen canine serum and urine has not been established.

OBJECTIVES

The purpose of this study was to determine the stability of osmolality in canine serum and urine stored frozen at -20°C and -80°C up to 90 days, and to assess the effect of storage temperature on osmolality measurement.

METHODS

Serum and urine samples collected from 5 healthy Greyhound dogs were aliquoted and stored at -20°C and -80°C until measurement. Osmolality, assessed by freezing-point depression, was measured at 0, 7, 14, 30, and 90 days of storage.

RESULTS

For both serum and urine, osmolality at day 7 was not statistically different from day 0, but osmolality at days 14, 30, and 90 was significantly lower than at day 0. There was no significant effect of storage temperature on serum osmolality. However, the osmolality of urine samples stored at -20°C was slightly, but significantly lower than the osmolality of those stored at -80°C.

CONCLUSIONS

Osmolality measurement in the serum and urine of healthy dogs appears to be stable for at least 7 days in frozen samples. The small changes observed after day 7 are unlikely to be relevant for individual patients, but could have implications in research study protocols.